Hazardous Materials Compliance and Labeling

The contract requires strict adherence to OSHA’s Hazard Communication Standard (29 CFR 1910.1200) for all pharmaceutical labeling to ensure workplace safety and regulatory compliance. This includes the accurate preparation, maintenance, and dissemination of Safety Data Sheets (SDS) for hazardous materials used or distributed under the scope of the agreement, with full attention to documentation accuracy, accessibility, and timely updates. Compliance must also account for regulatory exemptions provided under the Federal Food, Drug, and Cosmetic Act (FDCA), ensuring that pharmaceutical products subject to FDA oversight are appropriately handled without conflicting with OSHA requirements. The subcontractor must implement systems and processes to verify that all labeling meets federal standards, manage SDS records efficiently, and maintain internal audits to demonstrate continuous compliance across the pharmaceutical supply chain. The solicitation is issued under NAICS code 541620 for scientific and technical consulting services, targeting organizations capable of delivering specialized regulatory compliance expertise within the medical supply chain. The contract is associated with the Department of Defense’s Medical Supply Chain PHARM FSA, indicating its relevance to defense-related pharmaceutical operations. The response deadline is set for July 28, 2026, with a posted date of July 22, 2026, allowing a brief six-day window for proposals. The work is expected to support federal defense medical logistics, emphasizing the critical role of compliant labeling in ensuring safe handling, storage, and use of hazardous pharmaceutical materials in military and civilian healthcare settings. No set-aside or specific location details are provided, suggesting a flexible performance scope likely tied to nationwide or multi-site operations within the DoD’s pharmaceutical infrastructure.